Username Password
S&P 500: 1,351.68 Change: +0.14%

KERYX BIOPHARMACEUTICALS INC (KERX)

Overview
Price 3.30
Price Change Today 0.00 (0.00%)
P&P rating Rating: 2
Zacks Rank 4 - SELL
Open Price $0.00
Previous Close $3.30
Daily Range $0.00 - $0.00
52-Week Range $2.27 - $5.55
Volume 0
chart
Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.
Other Resources for KERX
zacks.com
Commentary
No Commentary Found for This Ticker.
Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.
 
Brokerage Analyst Recommendations
7 Brokerage Firms Covering KERX
 
 
Strong Buy
7
Buy
0
Hold
0
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1
 
KERX Ratings:BUY  SELL  HOLD
KERX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

3 Buy
2 Sell
 
Free Options Trader Guide
Top Buy Analysis
BUY: KERX Rating: 2
Company: KERYX BIOPHARMACEUTICALS INC.
Points: 1.62
Start Price: $2.77
Start Date: 03/11/2010 10:47 PM
Kenneth_Jezewski
Kenneth_Jezewski
P&P Score: 2.42
Recs:
hold long

Comments: 0 | Comment


Top Sell Analysis
SELL: KERX Rating: 2
Company: KERYX BIOPHARMACEUTICALS INC.
Points: 16.44
Start Price: $3.10
Start Date: 12/03/2009 10:31 PM
BearNekkid
BearNekkid
P&P Score: 0.48
Recs:

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
Nomadamon
98.55 04/15/10 3 little rocket stocks 1 04/15/10
AndrewGreenBull
97.65 12/01/09 DARA--Will It be the No.11? 0
Zacks_Analysts
0.00 06/09/10 Keryx Presents Encouraging Data - Analyst Blog 0
Zacks_Analysts
0.00 04/08/10 Zacks Analyst Blog Highlights: Monsanto Company, Keryx Biopharmaceuticals, Sanofi-Aventis, Roche and Pfizer - Press Releases 0
Zacks_Analysts
0.00 04/07/10 Keryx Gets Fast Track Status - Analyst Blog 0
Zacks_Analysts
0.00 03/26/10 Keryx's Loss Wider than Expected - Analyst Blog 0
Zacks_Analysts
0.00 10/01/09 Keryx Cancer Drug Impresses - Analyst Blog 0
Zacks_Analysts
0.00 09/25/09 Good News for Keryx - Analyst Blog 0
Commentary
BUY: KERYX BIOPHARMACEUTICALS INC. (KERX) Rating: 2
Start Price: $3.82
Points: -37.15
Created: 08/18/2010
3CMB,C1A,MR98,MBuy3

Comments: 0 | Comment

Recs:
 
BUY: KERYX BIOPHARMACEUTICALS INC. (KERX) Rating: 2
Start Price: $2.77
Points: +1.62
Created: 03/11/2010
hold long

Comments: 0 | Comment

Recs:
 
BUY: KERYX BIOPHARMACEUTICALS INC. (KERX) Rating: 2
Start Price: $3.18
Points: -10.06
Created: 04/05/2010

Comments: 0 | Comment

Recs:
 
SELL: KERYX BIOPHARMACEUTICALS INC. (KERX) Rating: 2
Start Price: $3.10
Points: +16.44
Created: 12/03/2009

Comments: 0 | Comment

Recs:
 
SELL: KERYX BIOPHARMACEUTICALS INC. (KERX) Rating: 2
Start Price: $12.15
Points: +64.92
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
Fiskhus 1.54 BUY One to Three Months 08/18/2010 $3.82 $3.30
(-4.90%)
-13.61% +23.54% -37.15 view
JJONES 99.64 BUY Three Plus Years 04/05/2010 $3.18 $3.30
(-4.90%)
+3.77% +13.83% -10.06
Kenneth_Jezewski 2.42 BUY One to Three Months 03/11/2010 $2.77 $3.30
(-4.90%)
+19.13% +17.51% +1.62 view
BearNekkid 0.48 SELL Three to Six Months 12/03/2009 $3.10 $3.30
(-4.90%)
+6.45% +22.89% +16.44
d1david 54.88 SELL Six Months to a Year 01/01/2008 $12.15 $3.30
(-4.90%)
-72.84% -7.92% +64.92
Sponsored Links